Publications by authors named "Yin-jie Zhang"

Background: Approximately 10% of patients with gastric cancer (GC) have a genetic predisposition toward the disease. However, there is scant knowledge regarding germline mutations in predisposing genes in the Chinese GC population. This study aimed to determine the spectrum and distribution of predisposing gene mutations among Chinese GC patients known to have hereditary high-risk factors for cancer.

View Article and Find Full Text PDF

In this study, our purpose was to explore the synergistic anti-tumor effect and mechanism of paclitaxel nanoparticles (PTX-NPs) combined with radiotherapy (RT) on human cervical carcinoma (HeLa). PTX-NPs were prepared by a solid dispersion method using methoxy poly(ethylene glycol)-poly(ɛ-caprolactone) (MPEG-PCL), which combined with RT exerted a potent and high efficient effect against cervical cancer. In vivo antitumor activity of PTX-NPs combined with RT, was estimated using nude mice carrying Hela cell xenograft tumor.

View Article and Find Full Text PDF

Tongluo Xingnao effervescent tablet (TLXNET) is a patented prescription, which comes from modified Xionggui decoction and can improve cognitive function. However, its effect on the urine metabolites and anti-dementia mechanism in the dementia model rats induced by hippocampal injection with Aβ25-35 remains unclear. The experiment focused on the changes in trajectory and inter-relationship among the urinary metabolite of rats in the blank group, Aβ25-35 hippocampal injection dementia model group and the TLXNET intervention group, in order to determine theirs characteristic metabolic markers and explain the anti-dementia effect of TLX-NET base on the change of metabolic trajectory of these bio-markers.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate how Tongluo Xingnao effervescent tablets affect learning and memory and the expression of Na(+)-K(+)-ATPase in the brains of rats with chronic cerebral ischemia.
  • Using a 2-VO method, researchers created a model of memory dysfunction in rats, divided them into various treatment groups, and administered drugs for 90 days before testing their memory and analyzing brain tissues.
  • Results showed that Tongluo Xingnao tablets improved escape latency and memory performance in tests compared to the model group, and the middle-dose group had better histopathological results and higher Na(+)-K(+)-ATPase expression.
View Article and Find Full Text PDF
Article Synopsis
  • A planar p-i-n light emitting diode was created using undoped GaAs/AlGaAs quantum wells and standard lithography techniques.
  • The device features a twin gate design, allowing for the close placement of two-dimensional electron and hole gases.
  • The electroluminescence shows high stability and distinct transition peaks, making it a strong candidate for electrically-driven single photon source applications.*
View Article and Find Full Text PDF

Objective: To study the effect of Tongluo Xingnao effervescent tablet on learning and memory of dementia rats induced by injection of Abeta25-35 in hippocampus and expression of insulin-degrading enzyme in hippocampus, in order to provide basis for preventing and treating senile dementia.

Method: The dementia rat model was established by injecting Abeta25-35 in hippocampus. The rats were divided into the model control group, the Aricept (1.

View Article and Find Full Text PDF

With an aim of developing novel protein tyrosine phosphatase (PTP) 1B inhibitors based on sugar scaffolds, a focused library of benzyl 6-triazolo(hydroxy)benzoic glucosides was efficiently constructed via the modular and selective Cu(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddtion (click chemistry). These glycoconjugates bearing alkyl chain length-varied bridges between the sugar and (hydroxy)-benzoic moieties were identified as new PTP1B inhibitors with selectivity over T-Cell PTP (TCPTP), SH2-Containing PTP-1 (SHP-1), SHP-2 and Leukocyte Antigen-Related Tyrosine Phosphatase (LAR). Molecular docking study sequentially elaborated the plausible binding modes of the structurally diverse sugar-based inhibitors with PTP1B.

View Article and Find Full Text PDF